Bright Peak Therapeutics
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $232M
Investors
- 11
About Bright Peak Therapeutics
Founded in 2017 by Vijaya R. Pattabiraman (CTO) and Jeffrey Bode and based in Basel, Switzerland, Bright Peak Therapeutics AG operates as a biotechnology company that focuses on the development of synthetic protein therapeutics for healthcare institutes to have a specific immuno-oncology indication, modification, and conjugation. In June 2024, Bright Peak Therapeutics, Inc. The company also has a presence in the US. The company specializes in developing next-generation precision immunotherapies through advanced protein engineering. The firm utilizes its proprietary chemical protein synthesis platform to create multifunctional immunotherapies for treating cancer and autoimmune diseases. Bright Peak's approach leverages protein design to enhance therapeutic efficacy and specificity. The company's pipeline includes a range of designer immunotherapies that are engineered to offer targeted and effective treatment options.
Who invested in Bright Peak Therapeutics
11 investors across 3 rounds
See all investors in Bright Peak Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bright Peak Therapeutics
Who invested in Bright Peak Therapeutics?
Bright Peak Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bright Peak Therapeutics raised?
Bright Peak Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bright Peak Therapeutics last raise money?
Bright Peak Therapeutics's most recent round on record is a Series C, in Jun 2024.
What does Bright Peak Therapeutics do?
Bright Peak Therapeutics is a biotechnology company.
Where is Bright Peak Therapeutics headquartered?
Bright Peak Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Bright Peak Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Bright Peak Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bright Peak Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.